Filing Details

Accession Number:
0001209191-17-029621
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-05-03 16:08:07
Reporting Period:
2017-05-02
Filing Date:
2017-05-03
Accepted Time:
2017-05-03 16:08:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
907654 Arca Biopharma Inc. ABIO In Vitro & In Vivo Diagnostic Substances (2835) 363855489
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1113661 J Daniel Mitchell 11080 Circlepoint Road
Suite 140
Westminster CO 80020
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-05-02 11,000 $2.71 11,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from$2.65 to $2.75. Upon request of the SEC staff, ARCA biopharma, Inc. (the "Company") or a security holder of the Company, the reporting personwill provide full information regarding the number of shares purchased at each separate price.